Cargando…
Insights into RNA binding by the anticancer drug cisplatin from the crystal structure of cisplatin-modified ribosome
Cisplatin is a widely prescribed anticancer drug, which triggers cell death by covalent binding to a broad range of biological molecules. Among cisplatin targets, cellular RNAs remain the most poorly characterized molecules. Although cisplatin was shown to inactivate essential RNAs, including riboso...
Autores principales: | Melnikov, Sergey V., Söll, Dieter, Steitz, Thomas A., Polikanov, Yury S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889946/ https://www.ncbi.nlm.nih.gov/pubmed/27079977 http://dx.doi.org/10.1093/nar/gkw246 |
Ejemplares similares
-
Mechanistic insights into the slow peptide bond formation with D-amino acids in the ribosomal active site
por: Melnikov, Sergey V, et al.
Publicado: (2019) -
Structural insights into the role of rRNA modifications in protein synthesis and ribosome assembly
por: Polikanov, Yury S., et al.
Publicado: (2015) -
Insights into the molecular mechanism of translation inhibition by the ribosome-targeting antibiotic thermorubin
por: Paranjpe, Madhura N, et al.
Publicado: (2022) -
Structural insights into the binding of bS1 to the ribosome
por: D’Urso, Gaetano, et al.
Publicado: (2023) -
The crystal structure of the Thermus aquaticus DnaB helicase monomer
por: Bailey, Scott, et al.
Publicado: (2007)